Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Genscript Biotech ( (HK:1548) ) has provided an announcement.
Genscript Biotech Corporation announced the grant of 624,540 Restricted Shares to its rotating chief executive officer and a director under the 2019 RSA Scheme. This move is part of the company’s strategy to align the interests of its executives with corporate performance, with vesting periods extending up to five years and performance targets in place. The inclusion of a clawback mechanism ensures that the company can reclaim equity incentives under certain conditions, such as misconduct or financial misstatements.
More about Genscript Biotech
Genscript Biotech Corporation is a company incorporated in the Cayman Islands, operating in the biotechnology industry. The company, along with its subsidiaries, focuses on providing innovative biotechnology products and services.
Average Trading Volume: 22,411,448
Technical Sentiment Signal: Buy
Current Market Cap: HK$36.41B
For a thorough assessment of 1548 stock, go to TipRanks’ Stock Analysis page.